Literature DB >> 8566598

Wheat bran suppresses potato starch--potentiated colorectal tumorigenesis at the aberrant crypt stage in a rat model.

G P Young1, A McIntyre, V Albert, M Folino, J G Muir, P R Gibson.   

Abstract

BACKGROUND & AIMS: Starch that escapes digestion in the small intestine (resistant starch [RS]) may act similarly to nonstarch polysaccharides in the colon. The aim of this study was to examine the effect of raw potato starch alone and in combination with wheat bran on tumor development and precancer events in a rat model of colorectal cancer.
METHODS: Three groups of rats received either a low-RS/low-fiber ("basic") diet, the basic diet containing raw potato starch as 20% of carbohydrate content, or the potato starch diet plus 10% of "wheat bran" fiber. Epithelial proliferation, aberrant crypt foci (ACF), and tumors were measured 6 and 20 weeks after a 10-week course of dimethylhydrazine.
RESULTS: Rats on the potato starch diet had tumors more frequently and had larger tumors than rats consuming the wheat bran or basic diets. Parallel effects on the density of ACF were found 6 weeks after the carcinogen. Although epithelial proliferation was significantly enhanced by potato starch compared with the basic diet, the addition of wheat bran did not suppress this enhancement.
CONCLUSIONS: This type-2 RS enhances epithelial proliferation, ACF density, and tumor formation. The addition of wheat bran to an RS-containing diet suppresses tumorigenesis, acting on events responsible for the formation of ACF but not the events controlling the hyperproliferative phase.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8566598     DOI: 10.1053/gast.1996.v110.pm8566598

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  15 in total

Review 1.  Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency.

Authors:  Denis E Corpet; Sylviane Taché
Journal:  Nutr Cancer       Date:  2002       Impact factor: 2.900

2.  Dietary fibre and intestinal microflora: effects on intestinal morphometry and crypt branching.

Authors:  J S McCullogh; B Ratcliffe; N Mandir; K E Carr; R A Goodlad
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

3.  Effect of olive oil on early and late events of colon carcinogenesis in rats: modulation of arachidonic acid metabolism and local prostaglandin E(2) synthesis.

Authors:  R Bartolí; F Fernández-Bañares; E Navarro; E Castellà; J Mañé; M Alvarez; C Pastor; E Cabré; M A Gassull
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

4.  Colonic butyrate- algesic or analgesic?

Authors:  P Kannampalli; R Shaker; J N Sengupta
Journal:  Neurogastroenterol Motil       Date:  2011-11       Impact factor: 3.598

5.  Differential dietary effects on colonic and small bowel neoplasia in C57BL/6J Apc Min/+ mice.

Authors:  C F Yu; L Whiteley; O Carryl; M D Basson
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

6.  The effects of short-chain fatty acids on colon epithelial proliferation and survival depend on the cellular phenotype.

Authors:  Mònica Comalada; Elvira Bailón; Oscar de Haro; Federico Lara-Villoslada; Jordi Xaus; Antonio Zarzuelo; Julio Gálvez
Journal:  J Cancer Res Clin Oncol       Date:  2006-05-17       Impact factor: 4.553

7.  Dietary fiber enhances TGF-β signaling and growth inhibition in the gut.

Authors:  Yanna Cao; Xuxia Gao; Weili Zhang; Guohua Zhang; Anthony K Nguyen; Xianghua Liu; Fernando Jimenez; Charles S Cox; Courtney M Townsend; Tien C Ko
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-03-31       Impact factor: 4.052

8.  Wheat bran affects the site of fermentation of resistant starch and luminal indexes related to colon cancer risk: a study in pigs.

Authors:  M J Govers; N J Gannon; F R Dunshea; P R Gibson; J G Muir
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

9.  Urokinase and the intestinal mucosa: evidence for a role in epithelial cell turnover.

Authors:  P R Gibson; I Birchall; O Rosella; V Albert; C F Finch; D H Barkla; G P Young
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

10.  Targeting cyclooxygenase-2 with sodium butyrate and NSAIDs on colorectal adenoma/carcinoma cells.

Authors:  Zhi-Hong Zhang; Qin Ouyang; Hua-Tian Gan
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.